FDA Approves New Drug For Breast Cancer

WASHINGTON (AP) _ Women with advanced breast cancer that other treatments have failed to stop gained a new option Tuesday with the approval of a novel drug made by GlaxoSmithKline PLC. <br/><br/>The drug,

Tuesday, March 13th 2007, 1:38 pm

By: News On 6


WASHINGTON (AP) _ Women with advanced breast cancer that other treatments have failed to stop gained a new option Tuesday with the approval of a novel drug made by GlaxoSmithKline PLC.

The drug, Tykerb, is to be taken once daily in pill form and is meant for women who have received prior treatment with the intravenous drug Herceptin and cancer drugs called taxanes and anthracyclines, the company said. The Food and Drug Administration approved Tykerb for use in conjunction with the chemotherapy drug Xeloda.

The results of a study published last year showed that Tykerb in combination with Xeloda delayed tumor growth for an average of 8 1/2 months, or about twice as long when compared to treatment with Xeloda alone. Tykerb worked so well that the international study was stopped early and all participants were offered the drug.
logo

Get The Daily Update!

Be among the first to get breaking news, weather, and general news updates from News on 6 delivered right to your inbox!

More Like This

March 13th, 2007

March 14th, 2024

December 4th, 2023

September 25th, 2023

Top Headlines

March 27th, 2024

March 27th, 2024

March 27th, 2024

March 27th, 2024